"Chromium: is it essential, pharmacologically relevant, or toxic?" J Trace Elem Med Biol
Cagrilintide vs AOD 9604 Mechanism: Cagrilintide: Amylin receptor agonist (appetite/satiety) AOD 9604: HGH fragment (fat metabolism) Completely different Weight loss: Cagrilintide: 10-12% body weight AOD 9604: 5-8% body weight (less robust data) Cagrilintide superior Clinical evidence: Cagrilintide: Extensive Phase 2/3 trials AOD 9604: Limited clinical data Cagrilintide better studied Side effects: Cagrilintide: GI effects common AOD 9604: Minimal side effects AOD 9604 better tolerated Combination potential: Could theoretically combine (different mechanisms) No clinical data on combination Cagrilintide + semaglutide better established Verdict: Cagrilintide more powerful, better evidence
Nierenberg AA, Kansky C, Brennan BP, Shelton RC, Perlis R, Iosifescu DV
Read our full post with GLP-1-friendly exercise ideas here: Exercising on GLP-1s GLPReset Hub Blog If you stop, your appetite is likely to return to its previous levels
This hypothesis, while mechanistically plausible, requires further experimental validation
